BR112013019519A2 - método de realce de crescimento capilar - Google Patents

método de realce de crescimento capilar

Info

Publication number
BR112013019519A2
BR112013019519A2 BR112013019519A BR112013019519A BR112013019519A2 BR 112013019519 A2 BR112013019519 A2 BR 112013019519A2 BR 112013019519 A BR112013019519 A BR 112013019519A BR 112013019519 A BR112013019519 A BR 112013019519A BR 112013019519 A2 BR112013019519 A2 BR 112013019519A2
Authority
BR
Brazil
Prior art keywords
hair growth
enhancement method
minoxidil
bimatoprost
compositions
Prior art date
Application number
BR112013019519A
Other languages
English (en)
Portuguese (pt)
Inventor
David F Woodward
Jenny W Wang
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of BR112013019519A2 publication Critical patent/BR112013019519A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A61K2800/592—Mixtures of compounds complementing their respective functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BR112013019519A 2011-01-31 2012-01-30 método de realce de crescimento capilar BR112013019519A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161437785P 2011-01-31 2011-01-31
PCT/US2012/023148 WO2012106249A2 (en) 2011-01-31 2012-01-30 Method of enhancing hair growth

Publications (1)

Publication Number Publication Date
BR112013019519A2 true BR112013019519A2 (pt) 2016-08-09

Family

ID=45688992

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013019519A BR112013019519A2 (pt) 2011-01-31 2012-01-30 método de realce de crescimento capilar

Country Status (10)

Country Link
US (3) US8932567B2 (https=)
EP (1) EP2670488A2 (https=)
JP (1) JP6017455B2 (https=)
KR (1) KR20140020895A (https=)
CN (1) CN103747775A (https=)
AU (2) AU2012212481A1 (https=)
BR (1) BR112013019519A2 (https=)
CA (1) CA2826232C (https=)
RU (1) RU2013139682A (https=)
WO (1) WO2012106249A2 (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102318450B (zh) 2008-02-05 2016-10-19 普林斯顿大学理事会 印刷电子设备
US8859616B2 (en) * 2011-01-21 2014-10-14 Allergan, Inc. Compounds and methods for enhancing hair growth
EP2670488A2 (en) 2011-01-31 2013-12-11 Allergan, Inc. Method of enhancing hair growth
CN105658221B (zh) * 2013-09-26 2022-05-10 高德美国际公司 用于治疗萎缩性皮肤瘢痕形成的前列腺素F2α及其类似物
WO2016159916A1 (en) * 2015-03-31 2016-10-06 Ogi̇g Sağlik Ürünleri̇ Ve Hi̇zmetleri̇ Sanayi̇ Ti̇caret Li̇mi̇ted Şi̇rketi̇ A foamy pharmaceutical formulation used in dermatological diseases
MX2018001843A (es) * 2015-08-13 2018-05-16 River Town Therapeutics Inc Composiciones y metodos para tratar alopecia.
JP7064820B2 (ja) * 2016-03-31 2022-05-11 ピアス株式会社 育毛剤、並びにε‐ポリリジンおよび／またはシャクヤク抽出物の使用
KR102017796B1 (ko) * 2016-07-28 2019-09-03 주식회사 큐어바이오 신규한 aimp1 단백질의 단편과 이를 유효성분으로 포함하는 발모 촉진용 조성물
US10512670B2 (en) 2016-08-08 2019-12-24 Scm Lifescience Co., Ltd. Pharmaceutical composition for preventing or treating hair loss comprising chemokine (C-X-C motif) ligand 1 (CXCL1) protein or CXCL1 protein and minoxidil as active ingredient
KR101849200B1 (ko) * 2017-01-19 2018-04-16 주식회사 효성 충격강도가 개선된 폴리케톤 조성물
KR101878795B1 (ko) * 2017-03-22 2018-08-16 주식회사 효성 내열성이 개선된 폴리케톤 조성물
KR102000217B1 (ko) * 2017-08-08 2019-07-15 에스씨엠생명과학 주식회사 Cxcl1 단백질 및 미녹시딜을 유효성분으로 포함하는 탈모 예방 또는 치료용 약학적 조성물
AU2019282155A1 (en) 2018-06-04 2021-01-07 Lars BRICHTA Topical compositions for stimulating hair growth
CA3107592A1 (en) * 2018-08-02 2020-02-06 Histogen, Inc. Conditioned medium and extracellular matrix compositions and uses thereof
US12539302B2 (en) 2019-08-07 2026-02-03 Aneira Pharma, Inc. Methods and compositions for the treatment of hair loss
LT3886799T (lt) 2019-08-07 2023-12-27 Aneira Pharma, Inc. Kompozicija, skirta plaukų slinkimo gydymui
CN110755286A (zh) * 2019-11-18 2020-02-07 童婧 一种有助于生发的发际线填充组合物
CN111110721A (zh) * 2020-01-19 2020-05-08 朱炜 一种毛发防脱再生的复合制剂及其使用方法
CA3182478A1 (en) * 2020-05-12 2021-11-18 Chemistry Rx Compositions for treating hair loss
BR102021003531A2 (pt) 2021-02-24 2022-08-30 Eurofarma Laboratorios S.A. Composição farmacêutica tópica espumável
KR102482658B1 (ko) * 2021-12-07 2022-12-29 주식회사 바이오빌리프 비마토프로스트를 포함하는 국소 투여용 약학 조성물
WO2025069091A1 (en) * 2023-09-29 2025-04-03 Pdfe Pharma Innovations - Fzco Novel topical pharmaceutical composition for prevention and treatment of hair loss

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4139619A (en) 1976-05-24 1979-02-13 The Upjohn Company 6-Amino-4-(substituted amino)-1,2-dihydro-1-hydroxy-2-iminopyrimidine, topical compositions and process for hair growth
US4968812A (en) 1989-06-23 1990-11-06 Shell Oil Company Spirolactonelactams
US5352708A (en) 1992-09-21 1994-10-04 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
CN1263442C (zh) * 2000-04-07 2006-07-12 大正制药株式会社 持续性毛发生长组合物
US7351404B2 (en) 2002-02-04 2008-04-01 Allergan, Inc. Method of enhancing hair growth
US7632867B2 (en) * 2007-10-31 2009-12-15 Meta Cosmetics, Llc Prostaglandin analog compositions to treat epithelial-related conditions
US20080275118A1 (en) * 2008-06-12 2008-11-06 Shaw Mari M Health and cosmetic composition and regime for stimulating hair growth and thickening on the head, including the scalp, eyelashes, and eyebrows, and which discourages hair loss
US8470833B2 (en) * 2009-12-15 2013-06-25 Mcneil-Ppc, Inc. Hair growth and/or regrowth compositions
EP2670488A2 (en) 2011-01-31 2013-12-11 Allergan, Inc. Method of enhancing hair growth

Also Published As

Publication number Publication date
CA2826232C (en) 2019-09-17
US20150290104A1 (en) 2015-10-15
US8932567B2 (en) 2015-01-13
US20180110711A1 (en) 2018-04-26
WO2012106249A3 (en) 2014-02-27
JP6017455B2 (ja) 2016-11-02
AU2017202667A1 (en) 2017-05-11
RU2013139682A (ru) 2015-03-10
US20120302588A1 (en) 2012-11-29
AU2012212481A1 (en) 2013-08-22
EP2670488A2 (en) 2013-12-11
AU2017202667B2 (en) 2019-02-21
CN103747775A (zh) 2014-04-23
WO2012106249A2 (en) 2012-08-09
KR20140020895A (ko) 2014-02-19
JP2014510042A (ja) 2014-04-24
CA2826232A1 (en) 2012-08-09
US9700503B2 (en) 2017-07-11

Similar Documents

Publication Publication Date Title
BR112013019519A2 (pt) método de realce de crescimento capilar
BR112018069876A2 (pt) composição cosmética, método para fotoestabilização de resveratrol, polidatina, ou uma mistura dos mesmos com baicalina e método
BR112014007382A2 (pt) anticorpos anti-erbb3 e seus usos
BR112014026740A2 (pt) anticorpo, composição, métodos para tratar um mamífero e para fornecer um anticorpo com adcc realçada, e, uso de um anticorpo
BRPI1106572B8 (pt) Composições que compreendem um retinoide e um inibidor de nfkb e seus métodos de uso
UY34701A (es) Formas sólidas de un profármaco de nucleótidos de tiofosforamidato
BR112016005816A2 (pt) Combinação de anticorpos anti-lag-3 e anticorpos anti-pd-1 para tratar tumores
BR112015010772A2 (pt) composição de enxágue tópica, uso de uma composição e método para tratar ou melhorar a pele de um indivíduo contra a acne
BR112013022246A2 (pt) formulações para alisamento capilar a base de queratina, métodos e sistemas
BR112014010162A2 (pt) uso de composição, método para melhorar o reconhecimento e/ou tratar ou prevenir função de reconhecimento prejudicada em um indivíduo, e composição
BR112013018352A2 (pt) composição de minociclina tópica e método
BR112014012050A2 (pt) método para produção de uma escova de dentes que tem uma cavidade interna
BR112013027500A2 (pt) liberação controlada de imunossupressores de nanotransportadores sintéticos
BR112014003463A2 (pt) métodos destinados a acentuar a hidratação da pele e melhorar a pele saudável
BR112016001919A2 (pt) composição cosmética e processo de tratamento cosmético
BR112015016018A2 (pt) composição para cuidado dos cabelos
WO2014095289A3 (en) Method of treating hair ageing
BR112012029919B8 (pt) Processo para preparação de 8-alcóxi [1,2,4] triazolo[1,5-c]pirimidin-2-aminas, substituídas na posição 5, e seus intermediários
BR112015026388A2 (pt) métodos e composições para cicatrização de feridas
BR112014029885A8 (pt) Composições tópicas, que contêm um retinoide, de tipo emulsão óleo em água
MX2015010404A (es) Composiciones y metodos para tratamiento y reparacion de tendones.
BR112015029815A2 (pt) composição cosmética para clarear uma pele e/ou cabelo de um indivíduo, conjunto para clarear uma pele e/ou um cabelo de um individuo, método cosmético para clarear uma pele e/ou um cabelo de um individuo, composição cosmética ou farmacêutica para aplicação na pele, cabelo e/ou unha de um indivíduo, conjunto para aplicar uma composição cosmética ou farmacêutica na pele cabelo e/ou unha de um individuo e método de administração de peróxido de hidrogênio na pele, cabelo e/ou unha de indivíduo.
BR112015031772A2 (pt) composições e métodos para o tratamento da pele
BR112016001677A2 (pt) Método para a redução ou inibição da progressão de um espessamento da pele em um indivíduo com essa necessidade e método para a regulação de uma resposta de egfr em um indivíduo com essa necessidade
BR112015029954A2 (pt) composição e processo para tratar as fibras queratínicas

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2395 DE 29-11-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.